Defective pathway cell activation systemic lupus erythematosus erratum Arthritis Rheum Jul sheep erythrocyte receptor surface component alternative antigen-independent pathway human cell activation response certain antibodies independent accessory cell signals direct measurement cell function pathway important differentiation thymocytes expression appearance cell receptor complex view impaired cell regulation immune responses patients systemic lupus erythematosus SLE activation peripheral blood lymphocytes antibodies SLE patients normal control subjects pathway response SLE patients SLE patients response control SLE low-responder patients normal-responder patients terms disease activity use antiinflammatory immunosuppressive medications Low responses normal coaddition submitogenic amount phorbol myristate acetate ng/ml low-responder patients responses removal non-T cells data indicate SLE patients responses pathway activation intrinsic cell defects regulatory influences non-T cells 